Today’s AI Top Pick: AZO

7/16/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

View the live AZO price forecast →

Today's pick · Low Float Bullish Consensus Deep RotationAZOBUY NOW8.2 / 107/16/2026

AZO is the cleanest 'quality on sale' setup in this pool. Fundamentals check every box the screen implies: PE 20.42 / fwdPe 16.91, operating margin 18.02%, profit margin 12.4%, analyst recom 1.42 (Strong Buy), and targetUpsidePct 33.8% on a $48.5B franchise. Unlike the microcap biotech names that dominate this list, AZO carries a 5.75 fundamental score with actual cash flows behind it and a bullish_prob of 1.0. The tape is where AZO separates from the pack. Position in the 21-bar range is 24.23% (1h), 5.32% (4h), 7.99% (1d), and 4.31% (1wk) — this is the opposite of chasing. Drawdown is -5.88% off the 4h high and -20.9% off the weekly high, which is exactly the pullback profile the prompt rewards. Meanwhile the forecast tape has quietly turned constructive: 1h fc_long +5.84%, 4h fc_long +14.94%, 1d fc_mid +22.13% / fc_long +24.83%. Three-timeframe forecast agreement + a deep-range entry is the ideal signature. Compare to the alternatives: MORN has better absolute fundamentals (score 8, PEG 0.72, ROE 30.66%) but is pinned at 96.89% of the daily range and 100% of the 4h range — you'd be chasing. HURN has recom 1.00 but its 1h fc is -10.32% and its weekly fc_long is -11.01%, i.e. the tape is fading the fundamentals. AMR has the best pure multi-TF alignment (+26–31% across every horizon) but fundamentals are ugly (operMargin -1.49%, profitMargin -1.83%) and UBS just went Neutral. AZO is the only name where strong fundamentals AND a non-stretched entry AND multi-TF forecast confirmation all line up on the same day. Why today, not wait: the daily has already put in the drawdown (-7.69% from 21-bar high) and the near-term forecasts (1h +1.11%, 4h +1.16%) suggest the selling exhaustion is in. Waiting for a bigger dip risks missing the mean-reversion up to the 1d fc_long of +24.83%. No adverse news — the July 10 'organizational changes' release was a routine internal announcement, not a guidance cut.

AZO forecast chart
Entry zone
$2,950–$2,985 (scale in around current $2,970.57; add on any flush to $2,930)
Stop loss
$2,830 (below the recent weekly-range low, ~-4.7% risk)
First target
$3,225 (approx. 1d fc_mid recovery, +8.6%)
Longer target
$3,600–$3,700 (aligns with 1d fc_long +24.83% and analyst upside of ~33.8%)
Risks
  • Weekly forecast is essentially flat (1wk fc_long -1.58%) — the longer-tenor tape isn't confirming the daily reversal, so this is a swing not a long hold.
  • Weekly drawdown of -20.9% and pos_in_21bar_range of 4.31% (wk) means AZO is still in a broken weekly structure; a break of $2,830 opens $2,700.
  • PerfYear -19.65% and PerfYtd -12.41% show sustained sector selling in consumer cyclical — a broader tape rollover would override this setup.
  • AZO reports earnings on a September cadence — any pre-announcement or guidance whisper could gap the stock through the stop.
  • debtEq is null in the data (AZO runs negative book equity due to buybacks) — not truly a red flag, but headline-risk sensitive if credit spreads widen.
Honorable mentions
AMRBest multi-timeframe forecast alignment in the pool (1h +30.97%, 4h +28.24%, 1d +26.42%, 1wk +28.43%) with position at 0% of 1h/4h range and -22.5% daily drawdown — textbook oversold-with-forecast-confirmation. Held back to #2 by weak fundamentals (operMargin -1.49%, salesYoY -19.15%) and UBS's fresh Neutral rating with $165 target roughly in line with spot.
MORNHighest fundamental score (8): PEG 0.72, ROE 30.66%, operMargin 22.52%, profitMargin 16.06%, recom 1.67, and 1wk fc_long +47.26%. Pushed to #3 only because entry is stretched — 96.89% of 1d range and 100% of 4h range means BUY_PULLBACK, not BUY_NOW.
Full ranking (30)
#SymbolVerdictScoreRead
1AZOBUY NOW8.2Quality fundamentals + deep-range entry (5–24% of range) + 1h/4h/1d forecast alignment (+5.8/+14.9/+24.8%).
2AMRBUY NOW7.6Cleanest 4-TF forecast alignment in the pool (+26–31% across all horizons) from the bottom of every range.
3MORNBUY PULLBACK7.4Best fundamentals (PEG 0.72, ROE 30.66%) but pinned at 96.89% of 1d range — wait for a $165 handle.
4HURNBUY PULLBACK6.4Recom 1.00 and fwdPe 11.15 are great, but 1h fc -10.32% and 1wk fc_long -11.01% say the tape is currently fading the fundamentals.
5TASKBUY PULLBACK6.1PEG 2.01, fwdPe 3.88, decent margins, but at 100% of 1h/4h/1d range with 1h fc -14.79% — needs to cool off first.
6MBRXBUY PULLBACK5.71d fc_long +88.7% with pos at 0.74% of daily range, but the June 30 -25% headline on soft MIRACLE interim data is a live overhang.
7EVGNWAIT5.61d fc_short +111.5% is enormous but profitMargin -638% and salesYoY -72.7% make this a lottery ticket, not a fundamental buy.
8BCDABUY PULLBACK5.51wk fc_long +250% from -32% drawdown is eye-catching, but ROE -950% and salesYoY -100% demand a much lower entry.
9WIMIWAIT5.4PE 0.59 and 1wk fc_long +119% look like a screen anomaly; RSI 30.53 and no analyst target upside make it uninvestable size.
10IDNBUY PULLBACK5.3Positive fundamentals (grossMargin 90.68%, Russell inclusion) and 0% of every range, but 1wk fc_long -1.99% means no confirmation on the longer tape.
11SHOEBUY PULLBACK5.0PE 10.91, fwdPe 8.01 and 1wk fc_long +74.86% from 0% of weekly range, but shortFloat 20.89% and recom 2.33 keep it as a secondary pick.
12GLMDWAIT4.9Positive patent news but $3.95M cap, 1d fc_short only +10.15%, and near-term 1h fc mid +9.4% doesn't justify the microcap risk.
13QNTMWAIT4.61d fc_long +76.8% and near_term_bullish 1.0, but ROE -984% and pos at 35% of daily range make it a speculation.
14LTRNWAIT4.5AI platform news is nice, but 1wk fc_long only +37% and 4h fc_long -5.24% show tape indecision.
15XTLBWAIT4.41wk fc_long +100.9% but 1h fc_short -18.2% — the intraday tape is rolling before the weekly setup can trigger.
16PRSOAVOID4.3Just signed a $25M ATM with Roth on July 2 — imminent dilution overhang neutralizes the forecast.
17NXTCAVOID4.1Merging into Avere with a $320M PIPE — the NXTC ticker essentially becomes a CVR, not a clean equity trade.
18DRMAWAIT4.01wk forecasts of +2557% are model noise, not signal; $5.2M cap and 1h fc_long -1.77% argue against chasing.
19HCWBAVOID3.91-for-6 reverse split just executed June 30 — reverse-split names statistically bleed for weeks post-effective.
20TOYOAVOID3.5Fundamental_score 8 on paper, but ~$50M share+warrant offering announced June 24 and expected_return_pct -23% flag active dilution.
21BCGWAIT3.4PE 12.73 and ROE 16.96% are fine, but 4h fc_short -18.18% and 1wk fc_long -6.63% mean the tape disagrees with the fundamentals.
22FLYXWAIT3.3Big 1d fc_long +120% and at 0% of every range post Jet.AI deal close, but perfYtd -66.7% and no earnings visibility keep it speculative.
23TTECAVOID3.0debtEq 11.65 and 1wk fc_short -51.45% — leverage plus a collapsing weekly forecast is a no-touch.
24USBCAVOID2.91d fc_long -14.12% and roe -247%; 1wk 'forecast' of +2125% is a model artifact.
25ARQQWAIT2.8Just settled misrep suit for $7M, but P/S 291, shortFloat 55.4%, and 1h fc_long -0.35% mean the easy money post-settlement is done.
26VWAVWAIT2.5Patent/defense narrative is real, but bullish_prob null and no fundamentals — narrative trade only.
27LZMHAVOID2.2PerfYear -98.9%, bullish_prob null, no analyst coverage — broken chart.
28SEGGAVOID2.0Active Nasdaq reporting deficiency and an outstanding $20M lawsuit against a short-seller — landmine profile.
29SSTAVOID1.8Fundamental_score -0.75, salesYoY -31%, grossMargin -6.71% — screen artifact, not a buy.
30AIMAVOID1.5P/S 79, profitMargin -14,123%, near_term_bullish 0 — avoid on all axes.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.